Odronextamab Plus CHOP Shows Early Efficacy in DLBCL
Elrexfio Maintains Responses in Elderly, Frail Patients With Multiple Myeloma
Fixed Duration Venclexta Combos Delay Progression in CLL Similarly to Imbruvica
Pediatric and AYA B-ALL Treatment Effective Without Total Body Irradiation